Clinical Research Pathways, a non-profit that advocates for increasing diversity in clinical research and expanding access to experimental drugs, biologics and medical devices, has added a new member to its board of directors.
30-May-2019 8:05 AM EDT Add to Favorites
Nonprofit Clinical Research Pathways announces two new members of its Board of Directors, from the Atlanta area
26-Feb-2019 10:05 AM EST Add to Favorites
Morehouse School of Medicine Awarded $200,000 to Train Minority Physicians for Recruiting Minorities in Clinical Trials
Under the three-year program, minority physicians will be recruited to conduct clinical trials—research studies that prospectively assign human participants or groups of humans to one or more health-related interventions to evaluate the effects on...
20-Sep-2018 12:00 PM EDT Add to Favorites
A new guide to helping patients understand two important options when they face serious or life-threatening illnesses: clinical trials and FDA's expanded access program to gain access to experimental/investigational drugs.
7-Aug-2018 11:00 AM EDT Add to Favorites
Clinical Research Pathways has launched an effort to learn what information and other resources physicians need to seek access to experimental drugs for desperately ill or terminal patients, using the expanded access program.
27-Jun-2018 9:00 AM EDT Add to Favorites
Two new directors add expertise to the Board for this independent public charity focused on diversity in research and expanded access to experimental drugs.
5-Jun-2018 8:00 AM EDT Add to Favorites
Name change for WCG Foundation
23-May-2018 10:00 AM EDT Add to Favorites
Free WCG Foundation Webinars Offer Insights on Speeding Access to Experimental Drugs for Intermediate-Size Patient Populations
WCG Foundation will host free webinars Jan. 25 and Feb. 5 on how to streamline the application process for experimental medications for intermediate-size populations of desperately ill patients.
9-Jan-2018 1:05 PM EST Add to Favorites
see all news
Clarifying the choices available to patients and their physicians when standard treatments for an illness fail. #expandedaccess #clinicaltrials
26-Mar-2019 1:05 PM EDT
New JAMA study an example of how diseases can affect minority populations differently. Find out what's being done to help solve this problem. Experts available @clinrespathways and Morehouse School of Medicine @msmedu for interviews.
9-Jan-2019 10:05 AM EST
How clinical trials can include more minority patients: involve the existing, trusted patient-physician relationship. Op Ed by Clinical Research Pathways leader posted in Scientific American @sciam
13-Dec-2018 2:05 PM EST
Why patients and physicians should stick with FDA's expanded access program to obtain access to experimental drugs -- blog post from Clinical Research Pathways leader
17-Jul-2018 2:05 PM EDT
Right to Try Legislation Fails; Why Keeping the FDA Central to the Expanded Access Process Is the Right Move
13-Mar-2018 9:05 PM EDT
There's Already a Better Alternative to Proposed "Right to Try" Legislation: Keep the FDA Involved in Expanded Access
12-Feb-2018 10:05 AM ESTsee all experts